These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy. Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A Ophthalmic Surg Lasers; 1995; 26(5):449-60. PubMed ID: 8963860 [TBL] [Abstract][Full Text] [Related]
9. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications. Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868 [TBL] [Abstract][Full Text] [Related]
10. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool. Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414 [TBL] [Abstract][Full Text] [Related]
19. Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals. Shields CL; Dalvin LA; Chang M; Mazloumi M; Fortin P; McGarrey M; Martin A; Yaghy A; Yang X; Vichitvejpaisal P; Mashayekhi A; Shields JA JAMA Ophthalmol; 2020 Feb; 138(2):136-146. PubMed ID: 31830238 [TBL] [Abstract][Full Text] [Related]
20. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Gündüz K; Shields CL; Shields JA; Cater J; Brady L Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]